The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Five-year subgroup analysis of tafasitamab + lenalidomide from the phase II L-MIND study in patients with relapsed or refractory diffuse large B-cell lymphoma.
 
Johannes Duell
Research Funding - MorphoSys; Regeneron
 
Pau Abrisqueta
Honoraria - Abbvie; AstraZeneca; Celgene; Gilead Sciences; Janssen
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; Janssen
Speakers' Bureau - Abbvie; AstraZeneca; Celgene; Gilead Sciences; Janssen
 
Martin H. Dreyling
Consulting or Advisory Role - Abbvie/Genentech (Inst); Acerta Pharma/AstraZeneca; Amgen; Bayer/Vital; Beigene; Celgene/Jazz; Genmab; Gilead Sciences; Incyte; Janssen-Cilag; Lilly Medical; morphosys; Novartis; Roche
Speakers' Bureau - Amgen; Bayer Health; Beigene; Celgene; Gilead Sciences; Janssen-Cilag; Roche Pharma AG
Research Funding - Abbvie (Inst); Bayer (Inst); Celgene (Inst); Janssen-Cilag (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Celgene; Janssen-Cilag; Roche Pharma AG
 
Gianluca Gaidano
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Incyte; Janssen; Roche
Speakers' Bureau - Abbvie; Janssen
 
Eva González Barca
Consulting or Advisory Role - Abbvie; BeiGene; EUSA Pharma; Gilead Sciences; Incyte; Janssen; Kyowa Kirin; Lilly O.
Speakers' Bureau - Abbvie; BeiGene; EUSA Pharma; Incyte; Janssen; Kyowa Kirin; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; EUSA Pharma; Janssen
 
Wojciech Jurczak
Consulting or Advisory Role - AstraZeneca; BeiGene; Roche
Research Funding - Acerta Pharma; BeiGene; Epizyme; Janssen-Cilag; MEI Pharma; Morphosys; Roche; Sandoz-Novartis; Takeda; TG Therapeutics; TG Therapeutics
 
Kami J. Maddocks
Honoraria - ADC Therapeutics; AstraZeneca/Merck; BeiGene; BMS; Celgene; Epizyme; Genentech; Genmab; Incyte; Karyopharm Therapeutics; Kite, a Gilead company; Lilly; MorphoSys; Pharmacyclics; Seagen
Research Funding - Bristol-Myers Squibb; Merck; Pharmacyclics
 
Tobias Menne
Honoraria - Celgene/Bristol-Myers Squibb; Janssen; Kite/Gilead; Novartis; Pfizer; Roche; SERVIER; Takeda
Consulting or Advisory Role - Amgen; Atara Biotherapeutics; Celgene/Bristol-Myers Squibb; Daiichi Sankyo Pharmaceutical; Janssen; Kite/Gilead; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Janssen; Novartis
Travel, Accommodations, Expenses - Amgen; Bayer; Celgene/Bristol-Myers Squibb; Janssen; Jazz Pharmaceuticals; Kite/Gilead; Kyowa Kirin; Pfizer; Takeda
 
Olivier Tournilhac
Honoraria - Abbvie; BeiGene; Gilead Sciences; Janssen; Takeda
Consulting or Advisory Role - Abbvie; BeiGene; Blueprint Medicines; Janssen-Cilag; Roche; Sandoz; Secura Bio; Takeda
Travel, Accommodations, Expenses - Abbvie; BeiGene; Gilead Sciences; Janssen-Cilag; Roche; Takeda
 
Abhishek Bakuli
Employment - MorphoSys
Consulting or Advisory Role - Ludwig-Maximilians-University Hospital
 
Aasim Amin
Employment - MorphoSys
Stock and Other Ownership Interests - PAION AG
 
Konstantin Gurbanov
Employment - MorphoSys
 
Gilles A. Salles
Stock and Other Ownership Interests - Owkin
Honoraria - Abbvie; Bayer; Incyte; Regeneron
Consulting or Advisory Role - Abbvie; BeiGene; BMS; Debiopharm Group; Epizyme; Genmab; incyte; Incyte; Ipsen; Janssen; Kite/Gilead; Loxo/Lilly; Miltenyi Biotec; Molecular Partners; morphosys; Nordic Nanovector; Novartis; RAPT Therapeutics; Roche/Genentech; Takeda; Velosbio
 
Zsolt Nagy
Consulting or Advisory Role - Abbvie; Janssen; Roche